Case number 2020-1876
Eli Lilly and Company v. Teva Pharmaceuticals > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 22, 2021 | 52 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [800975] [20-1876, 20-1877] [MVH] [Entered: 09/22/2021 08:46 AM] (1) |
| Aug 22, 2021 | 0 | ELI LILLY AND COMPANY v. TEVA PHARMACEUTICALS [OPINION] [precedential] (0) |
| Aug 16, 2021 | 51 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [792779] [20-1876, 20-1877, 20-1878] [MVH] [Entered: 08/16/2021 10:15 AM] (1) |
| Aug 16, 2021 | 50 | OPINION filed for the court by Lourie, Circuit Judge; Bryson, Circuit Judge and O'Malley, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [792778] [20-1876, 20-1877, 20-1878] [MVH] [Entered: 08/16/2021 10:14 AM] (31) |
| Jun 7, 2021 | 49 | Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Bryson, Circuit Judge and O'Malley, Circuit Judge.Arguing counsel: William Barrett Raich for Eli Lilly and Company and Mr. William M. Jay for Teva Pharmaceuticals International GmbH.Oral Argument Audio available here. [778780] [JCP] [Entered: 06/07/2021 01:31 PM] (0) |
| May 17, 2021 | 48 | Response to notice of oral argument from Appellee Teva Pharmaceuticals International GmbH. Service: 05/17/2021 by email. [775350] [20-1876] [William Jay] [Entered: 05/17/2021 11:57 AM] (1) |
| May 17, 2021 | 47 | Response to notice of oral argument from Appellant Eli Lilly and Company. Service: 05/17/2021 by email. [775273] [20-1876] [William Raich] [Entered: 05/17/2021 09:44 AM] (1) |
| Apr 21, 2021 | 46 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2106B. Case scheduled June 7, 2021. Response to Notice of Oral Argument due: 05/17/2021. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. The Counsel Telephonic Argument Orientation Information can be found here. Service as of this date by the Clerk of Court. [770330] [JCP] [Entered: 04/21/2021 05:13 PM] (1) |
| Apr 19, 2021 | 44 | The following conflict date submitted by William Barrett Raich for Eli Lilly and Company has been accepted by the court: 08/02/2021. [769637] [MJL] [Entered: 04/19/2021 03:52 PM] (0) |
| Apr 19, 2021 | 43 | Notice from Appellant Eli Lilly and Company regarding conflicts with oral argument. Service: 04/19/2021 by email. [769631] [20-1876] [William Raich] [Entered: 04/19/2021 03:47 PM] (3) |
| Apr 16, 2021 | 45 | 6 paper copies of Doc. No. [33] received from Appellee Teva Pharmaceuticals International GmbH. [769648] [VDW] [Entered: 04/19/2021 04:10 PM] (0) |
| Apr 14, 2021 | 42 | 6 paper copies of Doc. No. [37], [31], [25] received from Appellant Eli Lilly and Company. [769325] [VDW] [Entered: 04/16/2021 01:58 PM] (0) |
| Apr 13, 2021 | 41 | The following conflict dates submitted by William M. Jay for Teva Pharmaceuticals International GmbH have been accepted by the court: 06/09/2021, 06/10/2021, 06/11/2021, 08/06/2021. [768212] [MJL] [Entered: 04/13/2021 10:06 AM] (0) |
| Apr 12, 2021 | 40 | Notice from Appellee Teva Pharmaceuticals International GmbH regarding conflicts with oral argument. Service: 04/12/2021 by email. [768104] [20-1876] [William Jay] [Entered: 04/12/2021 04:26 PM] (2) |
| Apr 12, 2021 | 39 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before April 19, 2021. See Administrative Order No. 20-01 (Mar. 20, 2020). [767985] [KMH] [Entered: 04/12/2021 11:12 AM] (0) |
| Apr 12, 2021 | 38 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [767983] [KMH] [Entered: 04/12/2021 11:08 AM] (1) |
| Apr 2, 2021 | 32 | Notice of Correction to Doc No. [28] for Appellee Teva Pharmaceuticals International GmbH. Service: 04/02/2021 by email. [766494] [20-1876] [William Jay] [Entered: 04/02/2021 02:24 PM] (0) |
| Apr 2, 2021 | 33 | CORRECTED RESPONSE BRIEF FILED by Appellee Teva Pharmaceuticals International GmbH. Service: 04/02/2021 by email. (PENDING COMPLIANCE REVIEW) [766497] [20-1876] [William Jay] [Entered: 04/02/2021 02:30 PM] (0) |
| Apr 2, 2021 | 34 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellee Teva Pharmaceuticals International GmbH. Service: 04/02/2021 by email. [766498] [20-1876] [William Jay] [Entered: 04/02/2021 02:31 PM] (0) |
| Apr 2, 2021 | 35 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Eli Lilly and Company. Service: 04/02/2021 by email. [766502] [20-1876] [William Raich] [Entered: 04/02/2021 02:45 PM] (0) |
| Apr 2, 2021 | 36 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Eli Lilly and Company and Appellee Teva Pharmaceuticals International GmbH. Service: 04/02/2021 by email. [766503] [20-1876] [William Raich] [Entered: 04/02/2021 02:48 PM] (0) |
| Apr 2, 2021 | 37 | APPENDIX FILED by Appellant Eli Lilly and Company. Service: 04/02/2021 by email. (PENDING COMPLIANCE REVIEW) [766504] [20-1876] [William Raich] [Entered: 04/02/2021 02:57 PM] (0) |
| Mar 26, 2021 | 31 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Eli Lilly and Company. Service: 03/26/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [765100] --[Edited 03/30/2021 by KMH - compliance review complete] [William Raich] [Entered: 03/26/2021 02:24 PM] (0) |
| Feb 10, 2021 | 30 | ORDER granting motion to extend time to file brief [29] filed by Appellant Eli Lilly and Company. The reply brief is due no later than March 26, 2021. Service as of this date by the Clerk of Court. [755151] [LMS] [Entered: 02/10/2021 02:07 PM] (0) |
| Feb 5, 2021 | 29 | MOTION of Appellant Eli Lilly and Company to extend the time to 03/26/2021 to file brief. Service: 02/05/2021 by email. [754173] [20-1876] [William Raich] [Entered: 02/05/2021 12:47 PM] (0) |
| Jan 25, 2021 | 28 | MODIFIED ENTRY: BRIEF FILED by Appellee Teva Pharmaceuticals International GmbH. Service: 01/25/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [751661] --[Edited 01/29/2021 by KMH - compliance review complete] [William Jay] [Entered: 01/25/2021 07:43 PM] (0) |
| Dec 4, 2020 | 27 | **TEXT ONLY** ORDER granting motion to extend time to file brief [26] filed by Appellee Teva Pharmaceuticals International GmbH. The response brief is due 01/25/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [740423] [LMN] [Entered: 12/04/2020 03:54 PM] (0) |
| Dec 3, 2020 | 26 | MOTION of Appellee Teva Pharmaceuticals International GmbH to extend the time to 01/25/2021 to file brief. Service: 12/03/2020 by email. [740070] [20-1876] [William Jay] [Entered: 12/03/2020 02:58 PM] (9) |
| Nov 2, 2020 | 25 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Eli Lilly and Company. Service: 11/02/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [732866] --[Edited 11/02/2020 by LMN - compliance review complete] [William Raich] [Entered: 11/02/2020 01:35 PM] (472) |
| Sep 2, 2020 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file brief [23] filed by Appellant Eli Lilly and Company. The opening brief is due 11/02/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [719091] [EKD] [Entered: 09/02/2020 11:24 AM] (0) |
| Aug 28, 2020 | 23 | MOTION of Appellant Eli Lilly and Company to extend the time to 11/02/2020 to file the 09/21/2020. [Consent: unopposed]. Service: 08/28/2020 by email. [718326] [20-1876] [William Raich] [Entered: 08/28/2020 03:23 PM] (10) |
| Jul 22, 2020 | 22 | Certified list received. Service: 07/21/2020 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [709220] [20-1876, 20-1877, 20-1878] [EKD] [Entered: 07/22/2020 12:29 PM] (186) |
| Jun 26, 2020 | 21 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [9], ERROR: The contact information on the Entry of Appearance for S. Jivraj does not match the contact information in PACER. CORRECTION: Please ensure your contact information in PACER is up-to-date. Fed. Cir. R. 47.3(c)(1). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [703852] [EKD] [Entered: 06/26/2020 08:49 AM] (0) |
| Jun 25, 2020 | 16 | Entry of appearance for Natasha E. Daughtrey as of counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703613] [20-1876] [Natasha Daughtrey] [Entered: 06/25/2020 11:27 AM] (1) |
| Jun 25, 2020 | 18 | Docketing Statement for the Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703622] [20-1876] [William Jay] [Entered: 06/25/2020 11:36 AM] (3) |
| Jun 25, 2020 | 19 | Entry of appearance for Deborah Ann Sterling as of counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703791] [20-1876] [Deborah Sterling] [Entered: 06/25/2020 05:14 PM] (2) |
| Jun 25, 2020 | 20 | Entry of appearance for William H. Milliken as of counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703796] [20-1876] [William Milliken] [Entered: 06/25/2020 05:18 PM] (2) |
| Jun 25, 2020 | 15 | Entry of appearance for Elaine Herrmann Blais as of counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703607] [20-1876] [Elaine Blais] [Entered: 06/25/2020 11:16 AM] (1) |
| Jun 25, 2020 | 14 | Entry of appearance for Alexandra Lu as of counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703602] [20-1876] [Alexandra Lu] [Entered: 06/25/2020 11:09 AM] (1) |
| Jun 25, 2020 | 13 | Entry of appearance for William M. Jay as principal counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703595] [20-1876] [William Jay] [Entered: 06/25/2020 11:02 AM] (1) |
| Jun 25, 2020 | 12 | Entry of appearance for Edwina Clarke as of counsel for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703589] [20-1876] [Edwina Clarke] [Entered: 06/25/2020 10:54 AM] (1) |
| Jun 25, 2020 | 11 | Docketing Statement for the Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703549] [20-1876] [William Raich] [Entered: 06/25/2020 09:26 AM] (2) |
| Jun 25, 2020 | 10 | Certificate of Interest for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703548] [20-1876] [William Raich] [Entered: 06/25/2020 09:25 AM] (2) |
| Jun 25, 2020 | 9 | Entry of appearance for Sanjay M, Jivraj as of counsel for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703547] [20-1876] [William Raich] [Entered: 06/25/2020 09:23 AM] (1) |
| Jun 25, 2020 | 8 | Entry of appearance for Mark J. Stewart as of counsel for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703546] [20-1876] [William Raich] [Entered: 06/25/2020 09:21 AM] (1) |
| Jun 25, 2020 | 7 | Entry of appearance for Yieyie Yang as of counsel for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703544] [20-1876] [William Raich] [Entered: 06/25/2020 09:19 AM] (1) |
| Jun 25, 2020 | 6 | Entry of appearance for Pier D. DeRoo as of counsel for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703543] [20-1876] [William Raich] [Entered: 06/25/2020 09:17 AM] (1) |
| Jun 25, 2020 | 5 | Entry of appearance for William B. Raich as principal counsel for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703542] [20-1876] [William Raich] [Entered: 06/25/2020 09:15 AM] (1) |
| Jun 25, 2020 | 4 | Entry of appearance for Erin M. Sommers as of counsel for Appellant Eli Lilly and Company. Service: 06/25/2020 by email. [703541] [20-1876] [William Raich] [Entered: 06/25/2020 09:13 AM] (1) |
| Jun 25, 2020 | 17 | Certificate of Interest for Appellee Teva Pharmaceuticals International GmbH. Service: 06/25/2020 by email. [703617] [20-1876] [William Jay] [Entered: 06/25/2020 11:33 AM] (2) |
| Jun 12, 2020 | 3 | Note to File: The following cases are consolidated: 20-1876 Lead with 20-1877 and 20-1878 Member Cases. The parties must file all documents in the lead appeal only. [700883] [20-1876, 20-1877, 20-1878] [LMN] [Entered: 06/12/2020 04:17 PM] (0) |
| Jun 12, 2020 | 2 | ORDER consolidating appeals (20-1876 with 20-1877 and 20-1878). The Certified Lists are due no later than July 21, 2020. Service as of this date by the Clerk of Court. [700881] [20-1876, 20-1877, 20-1878] [LMN] [Entered: 06/12/2020 04:15 PM] (2) |
| Jun 11, 2020 | 1 | Appeal docketed. Received: 06/01/2020. [700501] Entry of Appearance is due 06/25/2020. Certificate of Interest is due on 06/25/2020. Docketing Statement is due 06/25/2020. Certified List is due on 07/21/2020. [LMN] [Entered: 06/11/2020 10:41 AM] (174) |
